Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: Dizziness; High temperature; Nausea; This is a spontaneous report from a contactable consumer received from the Regulatory Authority. The regulatory authority report number is GB-MHRA-WEBCOVID-202106011902532690-5YEYR, Safety Report Unique Identifier GB-MHRA-ADR 25400670 . A 35-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 21May2021 (Lot Number: EW4109) as first dose, single for COVID-19 immunization. Medical history included suppressed lactation and depression. from an unknown date. Patient has not had symptoms associated with COVID-19; Patient is not enrolled in clinical trial. Concomitant medication included citalopram taken for depression, start and stop date were not reported. On 01Jun2021, the patient experienced dizziness, high temperature and nausea. The outcome of the events was not recovered. The events were considered medically significant. The patient underwent lab tests and procedures which included No - Negative COVID-19 test. Patient has not tested positive for COVID-19 since having the vaccine. No follow-up attempts are possible. No further information is expected.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166